From June 14 to 15, 2025, the "First Academic Annual Meeting of the Biomedical Technology Branch of the Chinese Society of Plastic and Aesthetic Surgery" was grandly held in Beijing. This conference was hosted by the Chinese Society of Plastic and Aesthetic Surgery, co-organized by the Biomedical Technology Branch of the Chinese Society of Plastic and Aesthetic Surgery and Peking University Third Hospital, with the theme of "Integration and Innovation · Standardized Development." The focus was on the application and cutting-edge breakthroughs of biomedical technology in the field of plastic and aesthetic surgery. It gathered numerous experts and scholars from government departments, research institutes, medical institutions, enterprises, and universities to exchange reports on current international and domestic advanced minimally invasive plastic and aesthetic techniques, widely concerned scar treatment and management, and reconstructive plastic surgery techniques.

Dr. Sun Bianyou, the founder of Bakang Medical and a scar treatment expert, was invited to attend this conference and delivered a special report titled "Practice of Individualized Superficial Radiotherapy for Keloids." From multiple case studies, techniques, and perspectives, he comprehensively shared Bakang Medical's explorations, practices, and systematic solutions in the field of scar radiotherapy.

Patient-Centered Approach: Promoting Both Individualized and Standardized Radiotherapy

Dr. Sun pointed out that keloid treatment is far from a one-size-fits-all approach and requires highly individualized responses. Traditional high-dose short-term radiotherapy often carries significant tissue repair burdens, strong side effects, and high recurrence rates. Through long-term clinical experience, Bakang has proposed individualized superficial radiotherapy plans for different patients: Adjusting KV values, dose fractionation, and irradiation intervals based on scar thickness, location, growth state, and patient time windows, supplemented with drug injections and surgical design, to achieve a balance between comfort, safety, and effectiveness.

For example, in the treatment of high-recurrence areas like earlobes, Bakang uses a "postoperative immediate/subsequent staged radiotherapy + multiple zone irradiation + intralesional injection" protocol, effectively controlling recurrence while maintaining aesthetic appearance. For complex facial and chest scars, a "layered surgery + skin graft reimplantation + low-dose superficial radiotherapy + combined phototherapy" approach is used to achieve both high recovery and minimal trauma.

Dr. Sun emphasized: "Keloid treatment should not rely solely on surgery or a single technique but requires individualized plans and multidisciplinary collaboration." His presentation included multiple complex case treatment pathways, irradiation zoning techniques, and strategies for postoperative pigmentation, which received high attention and recognition from the experts present.

Beyond Techniques, Emphasizing 'Methodology'

In his speech, Dr. Sun highlighted several technical consensus and operational philosophies in scar radiotherapy at Bakang:

• Individual Time Scheduling: For patients with only one month or three months available, flexible treatment plans are tailored based on their scar conditions.

• Zonal Irradiation and Angle Reconstruction: For curved areas like the nostrils, ears, and cheeks, Bakang employs zonal irradiation and vertical beam strategies to avoid blind spots and uneven dosing.

• Management of High-Sensitivity Reactions: For patients with radiation dermatitis or vitiligo, treatment intervals are extended to 40-80 days per session to reduce skin reactions.

• Special Recurrence Cases: For patients who have received Sr-90 or isotope treatments elsewhere and developed radiogenic vitiligo with continued keloid growth, many doctors may no longer treat them or resort to surgery. Bakang, however, can still provide safe re-treatment through evaluation, zonal protection, and plan adjustments to address the problem of persistent keloid growth.

Dr. Sun repeatedly stressed that for such patients, primary physicians should actively communicate with radiation oncologists, clarify their viewpoints, and extend treatment intervals, using small, frequent doses to ensure both efficacy and safety.

Furthermore, Bakang has partnered with the CDC to apply for a patent on "radiotherapy," effectively solving issues of "radiation scatter" and "non-target area damage" in traditional radiotherapy, advancing radiotherapy equipment from "safe and usable" to "precise and controllable."

From Treatment to Follow-Up, Building a Closed-Loop Management System

"The best treatment is just a stopgap measure; continuous follow-up is the key to preventing scar recurrence."

Bakang has established a standardized follow-up work mechanism, dynamically observing scar changes, pigmentation reactions, and recurrence signals through postoperative photo comparisons, symptom scoring, and remote consultations. This ensures that every patient receives at least two years of long-term monitoring and management. Follow-up data also provides important support for Bakang's technical optimization, efficacy assessment, and research.

Vision: To Be a Long-Term Contributor in the Field of Scars

As a specialized medical institution with years of experience in scar treatment, Bakang consistently adheres to the principle of being "patient-centered" and operates under the philosophy that "prevention is better than treatment." Emphasizing interdisciplinary collaboration and full-cycle management, Bakang is committed to providing one-stop, high-quality treatment solutions for scar patients.

In the future, Bakang will continue to support research on the mechanisms of scar-related diseases, the formulation of standardized guidelines, and technological transformation, working together with industry experts to bring more scientific and effective treatment solutions to scar patients.